Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG

2026-07-08 · Source: The AI Journal · Field: Business & Management — Corporate Strategy & Leadership, Marketing, Branding & Advertising, Consulting & Professional Services · Depth: Novice, medium

Summary

The global cell culture media market, valued at US\$5.3 billion in 2026, is projected to reach US\$12.9 billion by 2033, growing at a CAGR of 13.6%. This expansion is primarily driven by the increasing demand from biologics manufacturing, the rapid commercialization of cell and gene therapies, and the growing adoption of serum-free and chemically defined production systems. Serum-free media is expected to hold 38% of the market share, while chemically defined media is anticipated to be the fastest-growing segment. Biopharmaceutical production will account for approximately 44% of the market. North America leads with 42% of the market, with Asia Pacific forecast for the fastest growth. Key players like Thermo Fisher Scientific, Merck KGaA, and Lonza Group are focusing on innovation and capacity expansion. Thermo Fisher Scientific notably promotes Gibco™ BenchStable™ media, designed for ambient storage to enhance sustainability and operational efficiency.

Key takeaway

For biopharmaceutical executives evaluating supply chain resilience and sustainability, the shift towards chemically defined and serum-free cell culture media presents a critical opportunity. You should prioritize suppliers offering these advanced formulations to enhance batch consistency and meet evolving regulatory standards. Consider solutions like Thermo Fisher Scientific's Gibco™ BenchStable™ media to reduce cold-chain logistics costs. Investing in these solutions can streamline operations and improve environmental impact.

Key insights

The cell culture media market is rapidly expanding, driven by biopharma and cell/gene therapies, with a strong shift towards serum-free and chemically defined formulations.

Principles

• Chemically defined media improves consistency.
• Serum-free media reduces contamination risks.
• Ambient-stable media enhances sustainability.

In practice

• Adopt serum-free media for regulatory compliance.
• Implement chemically defined media for yield.
• Utilize ambient-stable media to reduce cold-chain.

Topics

• Cell Culture Media
• Biologics Manufacturing
• Cell and Gene Therapy
• Serum-Free Media
• Chemically Defined Media
• Biopharmaceutical Market

Best for: Entrepreneur, Investor, Consultant, Executive

Related on AIssential

• ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing — AI-driven virtual cell platforms can precisely guide cell behavior to enhance biomanufacturing efficiency and scalability.
• Epigenetics Market worth $3.92 billion by 2031 | MarketsandMarkets™ — The epigenetics market is poised for substantial growth, driven by diverse applications in research and medicine and advanced technological adoption.
• How leftover fish skins landed this founder a billion-dollar exit: ‘My philosophy has always been to have fun’ — Transforming industrial byproducts into high-value medical solutions can yield significant economic success.
• Non-invasive profiling of the tumour microenvironment with spatial ecotypes — A new machine learning framework enables non-invasive profiling of tumor microenvironment spatial ecotypes from liquid biopsies, predicting immunotherapy response.
• Cricketer Pat Cummins backs longevity startup Everlab’s $65 million Series A - Startup Daily — AI-enhanced preventative healthcare leverages biomarker diagnostics to detect early health issues and coordinate personalized care.
• Weekly Dose of Optimism #197 — Advanced technologies are accelerating progress across architecture, medicine, defense, and manufacturing, driving significant breakthroughs.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by The AI Journal.